Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
34,079,994
-
Shares change
-
+1,331,864
-
Total reported value, excl. options
-
$313,536,434
-
Value change
-
+$13,703,166
-
Put/Call ratio
-
0%
-
Number of buys
-
40
-
Number of sells
-
-27
-
Price
-
$9.20
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2017
92 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q4 2017.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34,079,994 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,279,526 shares), BAKER BROS. ADVISORS LP (2,991,775 shares), PERCEPTIVE ADVISORS LLC (2,685,882 shares), FMR LLC (2,327,520 shares), Foresite Capital Management IV, LLC (2,254,502 shares), Redmile Group, LLC (2,002,265 shares), Vanguard Group Inc (1,779,307 shares), FRANKLIN RESOURCES INC (1,448,700 shares), Abingworth LLP (1,147,077 shares), and FARALLON CAPITAL MANAGEMENT LLC (1,100,000 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.